The company focuses its activities on the development of applications for the prevention of stroke caused by atrial fibrillation by an improved detection of paroxysmal atrial fibrillation. Several applications are already in use at medical practices and clinics, especially stroke units. The core of the products SRAdoc/SRA24 and SRAclinic is a fully automated detection of atrial fibrillation episodes and the identification of patients with an increased risk for paroxysmal atrial fibrillation with the help of a mathematical algorithm. The superiority of this method has been proven by clinical studies. The applications are web based and are easy and reliably integrated into each practice or clinic without any major effort.